Search Results for keywords:"diversion prevention"

Found 2 results
Skip to main content

Search Results: keywords:"diversion prevention"

  • Type:Notice
    Citation:90 FR 10730
    Reading Time:about a minute or two

    Sharp Clinical Services, LLC has submitted an application to register as an importer of certain controlled substances. The purpose of this registration is to import these substances for distribution and clinical trials, but not for commercial sales of finished products. The public can submit comments or objections electronically until March 28, 2025, and requests for a hearing on the application must be sent to the Drug Enforcement Administration by the same date.

    Simple Explanation

    Sharp Clinical Services, LLC wants to bring in special medicines that they can use for tests, but they won't sell them in stores; people can tell the government if they have any thoughts or questions until March 28, 2025.

  • Type:Notice
    Citation:90 FR 9555
    Reading Time:about 2 minutes

    The Drug Enforcement Administration (DEA) has announced that the University of Kentucky Cannabis Center has applied to become a registered bulk manufacturer of controlled substances, specifically marihuana. This application, filed on July 1, 2024, aims to allow the center to produce bulk active pharmaceutical ingredients for research purposes. Interested parties can comment on or object to this application until April 14, 2025, through the Federal eRulemaking Portal. DEA will review the application to ensure it complies with laws and regulations, focusing on preventing the potential diversion of the controlled substance.

    Simple Explanation

    The University of Kentucky wants permission to grow a special kind of plant called marijuana for research. The government is asking people to share their thoughts or any objections about this until April 14, 2025.